Sequencing bispecific antibodies and CAR T cell therapy in multiple myeloma with prior exposure to BCMA-targeted therapies.

被引：0
|
作者：
Patel, Urvi
Oluwole, Olalekan O.
Kassim, Adetola
Jayani, Reena
Belliveau, Paul
Savani, Bipin
Dholaria, Bhagirathbhai R.
机构：
[1] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Massachusetts Coll Pharm & Hlth Sci, Worcester, MA USA
[4] Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20049
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Patient perspectives on BCMA-targeted therapies for multiple myeloma: A survey conducted in a patient advocacy group
    Ahlstrom, Jennifer M.
    Lin, Dee
    Sweeney, Nathan W.
    Wu, Bingcao
    Gries, Katharine
    Kim, Nina
    Patel, Saurabh
    Sborov, Douglas W.
    Berdeja, Jesus G.
    Anderson, Larry D., Jr.
    Huo, Jinhai
    Hydren, Jay R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [32] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng
    Li, Chenggong
    Jiang, Huiwen
    Zhao, Xinying
    Huang, Zhiping
    Jin, Dan
    Guo, Tao
    Kou, Haiming
    Liu, Lin
    Tang, Lu
    Yin, Ping
    Wang, Zhihui
    Ai, Lisha
    Ke, Sha
    Xia, Yimeng
    Deng, Jun
    Chen, Lei
    Cai, Li
    Sun, Chunyan
    Xia, Linghui
    Hua, Gaoquan
    Hu, Yu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [33] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Heng Mei
    Chenggong Li
    Huiwen Jiang
    Xinying Zhao
    Zhiping Huang
    Dan Jin
    Tao Guo
    Haiming Kou
    Lin Liu
    Lu Tang
    Ping Yin
    Zhihui Wang
    Lisha Ai
    Sha Ke
    Yimeng Xia
    Jun Deng
    Lei Chen
    Li Cai
    Chunyan Sun
    Linghui Xia
    Gaoquan Hua
    Yu Hu
    Journal of Hematology & Oncology, 14
  • [34] BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting
    Zheng, Huijian
    Xian, Huajian
    Zhang, Wenjie
    Lu, Chaoqun
    Pan, Renyao
    Liu, Han
    Xu, Zhenshu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2025, 18 (01)
  • [35] BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease
    Hagen, Melanie
    Bucci, Laura
    Boeltz, Sebastian
    Noethling, Danae-Mona
    Rothe, Tobias
    Anoshkin, Kirill
    Raimondo, Maria G.
    Tur, Carlo
    Wirsching, Andreas
    Wacker, Jochen
    Duesing, Christina
    Distler, Jorg H. W.
    Kuwert, Torsten
    Bozec, Aline
    Ramming, Andreas
    Schett, Georg
    Grieshaber-Bouyer, Ricardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (09): : 867 - 869
  • [36] Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03):
  • [37] BCMA CAR T-cell therapy arrives for multiple myeloma: a reality
    Cho, Shih-Feng
    Anderson, Kenneth C.
    Tai, Yu-Tzu
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [38] BCMA-directed CAR T-cell therapy in multiple myeloma
    Cookson, Emma
    LANCET HAEMATOLOGY, 2020, 7 (07): : E505 - E505
  • [39] Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma
    Miller, Kevin
    Hashmi, Hamza
    Rajeeve, Sridevi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Single-Cell Profiling Reveals Contribution of Tumor Extrinsic and Intrinsic Factors to BCMA-Targeted CAR-T Cell Efficacy in Multiple Myeloma
    Melnekoff, David T.
    Ghodke-Puranik, Yogita
    Van Oekelen, Oliver
    Aleman, Adolfo
    Upadhyaya, Bhaskar
    Sebra, Robert
    Jagannath, Sundar
    Lagana, Alessandro
    Parekh, Samir
    BLOOD, 2021, 138
12345